imipenem, anhydrous has been researched along with Cholestasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anjary, A; Bende, F; Burciu, C; Dalati, S; Gadour, E; Horhat, FG; Miuțescu, B; Moga, T; Popescu, A; Rațiu, I; Sabuni, O; Turcu-Stiolica, A; Ungureanu, BS; Vuletici, D | 1 |
| Chan, CY; Cheng, AF; French, GL; Ko, TC; Lai, CW; Leung, JW | 1 |
2 other study(ies) available for imipenem, anhydrous and Cholestasis
| Article | Year |
|---|---|
Identification of Microbial Species and Analysis of Antimicrobial Resistance Patterns in Acute Cholangitis Patients with Malignant and Benign Biliary Obstructions: A Comparative Study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Ceftazidime; Cholangitis; Cholestasis; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Meropenem; Retrospective Studies | 2023 |
Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin.
Topics: Adult; Aged; Aged, 80 and over; Bile; Cholestasis; Cilastatin; Female; Humans; Imipenem; Infusions, Intravenous; Liver; Male; Middle Aged | 1992 |